Advanced Formulation Approaches for Targeted Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (31 December 2019) | Viewed by 108406
Special Issue Editors
Interests: organic–inorganic hybrid nanocomposites; oral protein delivery; nanomedicine, targeted drug delivery
Special Issues, Collections and Topics in MDPI journals
Interests: PEGylation; protein stability; nanomedicine; dendrimers; targeted drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Targeted drug delivery is an approach for delivering therapeutics to a patient in a manner that accumulates drugs selectively in the site of action relative to others in the body. The advantages of targeted drug delivery are especially evident in cancer chemotherapy. The selective delivery of cytotoxic drugs to cancer cells allows high local drug concentrations in the target cells while minimizing toxicity to normal cells. Nanoparticles have been one of the main subjects in the area of targeted drug-delivery. Recent advances in nanotechnology facilitate the development of more elaborated targeted-delivery systems for various therapeutics via active targeting or passive targeting.
This Special Issue of Pharmaceutics focuses on new strategies and advanced formulation approaches for targeted drug-delivery including liposomes, polymeric nanoparticles, dendrimers, nanocomposites, and antibody drug conjugates. We welcome articles dealing with all aspects of targeted drug-delivery systems and invite researchers and drug developers to publish their original research or review articles with expert opinions and perspectives in the area of therapeutics.
Prof. Dr. Hyo-Kyung Han
Prof. Dr. Dong Hee Na
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- targeted drug delivery;
- nanoparticles;
- nanomedicine;
- nanocarriers;
- liposome;
- micelles;
- dendrimers;
- nanocomposites;
- antibody–drug conjugates;
- formulation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.